Sumeray Mark

Avg. Two Year Performance

No purchase track record

77% Avg. Sale Return

33% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(5%)	(5%)	18%	54%	77%
Sale Success Rate	5 of 9	7 of 9	8 of 9	9 of 9	9 of 9

Aegerion Pharmaceuticals, I...

Drugs » Drug Manufacturers - Major

Chief Medical Officer:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--